Revolution Medicines Inc. Common Stock vs State Street Real Estate Select Sector SPDR ETF — how do they compare? Revolution Medicines Inc. Common Stock trades at $189.32 (market cap $40.32B), while State Street Real Estate Select Sector SPDR ETF trades at $41.58 (market cap $7.61B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 5.3× State Street Real Estate Select Sector SPDR ETF's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, State Street Real Estate Select Sector SPDR ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Revolution Medicines Inc. Common Stock for 0 Days and State Street Real Estate Select Sector SPDR ETF for 75 Days on average.
| RVMD | XLRE | |
|---|---|---|
Market Cap | $40.32B | $7.61B |
Volume | 4,855,734 | 7,876,569 |
Sector | Health | Sector/Thematic |
52-Week High | $221.15 | $46.01 |
52-Week Low | $47.50 | $40.01 |
Typical Hold Time | 0 Days | 75 Days |
Enterprise Value | $37.02B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XLRE, the State Street Real Estate Select Sector SPDR ETF, trades at $41.61, up 2.56% on the day, but technical indicators signal a bearish trend with moving averages and overall momentum favoring sellers. The ETF offers a low expense ratio of 0.08% and focuses on 30 U.S. large-cap real estate holdings, providing concentrated exposure to the domestic market. Recent news highlights comparisons with global real estate ETFs and discussions on value amid rising bond yields.
The outlook for XLRE is cautious due to bearish technicals and sensitivity to interest rate fluctuations, though its low cost and U.S. focus present a streamlined real estate investment option. Key risks include macroeconomic pressures from potential rate hikes and sector underperformance relative to digital infrastructure themes, requiring careful monitoring of Fed policy and real estate market dynamics.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →XLRE tracks the Real Estate Select Sector Index, providing exposure to S&P 500 real estate companies. It focuses on equity REITs across residential, industrial, and healthcare sub-sectors, with top holdings like Welltower, Prologis, and American Tower.
Read more on XLRE →